How to Get Bimatoprost Online in Amsterdam
Searching for Bimatoprost online in Amsterdam? This medication is not yet approved for use in the EU. Discover how Hi-Doctor connects you with EU-licensed doctors for approved weight-loss treatments.
DIRECT ANSWER
An online consultation lets an EU-licensed doctor review your case and, if appropriate, issue a prescription that is valid across the EU.
Less than 4 hours on average
Prescription issued in less than 4 hours on average if approved.
EU-licensed doctors
Every case is reviewed by a licensed clinician.
Valid across the EU
Approved prescriptions can be used at any EU pharmacy.
In this article
If you're in Amsterdam and searching for Bimatoprost online, it's crucial to understand its current status. Bimatoprost is an experimental peptide still undergoing clinical trials and is not yet approved for prescription in the EU. This means Hi-Doctor does not currently prescribe Bimatoprost. However, we can connect you with EU-licensed doctors who provide online consultations for approved weight-loss medications. Get your consultation for just 25 €, receive a prescription in under 24 hours if appropriate, and pick up your medication at any EU pharmacy.
How it works — get your consultation in 4 steps
Getting a prescription for EU-approved weight-loss medication through Hi-Doctor is straightforward and convenient. Everything happens through our secure online platform, eliminating waiting rooms and in-person visits.
- Complete an online questionnaire: You provide your medical history and current health status. This takes just a few minutes.
- EU-licensed doctor reviews your case: An experienced, EU-licensed doctor individually assesses your information. They determine if an approved treatment is safe and appropriate for you.
- Receive a REMPE prescription in <24 hours: If the doctor finds treatment appropriate, they issue a Receta Médica Privada Electrónica (REMPE) – Spain's official digital private prescription standard. You receive a downloadable PDF file inside your Hi-Doctor account and by email. This costs 25 €. Money-back guarantee: If the doctor determines the treatment is NOT appropriate for you, your 25 € fee is refunded immediately. You pay nothing.
- Pick up at any EU pharmacy: You can print the PDF prescription or show it on your phone at any pharmacy in the Netherlands or any other EU country. Pharmacists review the PDF and may dispense a locally-marketed equivalent. Please note that pharmacists retain the right to refuse dispensing.
| Feature | Hi-Doctor Online Consultation | Traditional Clinic Visit |
|---|---|---|
| Cost | 25 € (money-back guarantee) | Varies, often higher |
| Time to Prescription | <24 hours (if approved) | Days to weeks |
| Location | Anywhere with internet | Physical clinic |
| Prescription Type | REMPE (EU-wide recognition) | Local standard |
| Privacy | Fully private, RGPD-compliant | Less private |
Who qualifies
Eligibility for prescription weight-loss medication is determined by our EU-licensed doctors based on your individual health profile and medical history. Generally, these medications are prescribed for individuals with obesity (BMI >30) or those who are overweight (BMI >27) with at least one weight-related comorbidity such as high blood pressure or type 2 diabetes. The doctor will assess your case through the secure online questionnaire.
Bimatoprost is not currently an option as it is still in clinical trials and not approved for use in the EU.
What the medication actually does
Bimatoprost is a peptide that acts as a triple agonist, targeting GLP-1, GIP, and glucagon receptors. This multi-faceted approach aims to improve blood sugar control and promote significant weight loss. However, since Bimatoprost is not yet approved, Hi-Doctor focuses on EU-approved alternatives. These include:
- Wegovy (semaglutide): A GLP-1 receptor agonist specifically approved for chronic weight management.
- Mounjaro (tirzepatide): A dual GLP-1 and GIP receptor agonist, approved for type 2 diabetes, showing significant weight loss in clinical trials for obesity management.
- Saxenda (liraglutide): Another GLP-1 receptor agonist, approved for weight management.
These medications work by mimicking natural hormones that regulate appetite and blood sugar, leading to reduced food intake and improved metabolic control.
Side effects and when to stop
All medications, including approved weight-loss treatments, carry potential side effects. Common side effects for GLP-1 and GIP agonists can include nausea, vomiting, diarrhoea, constipation, and abdominal pain. These are usually mild and temporary. More serious side effects are rare but can include pancreatitis or gallbladder issues.
Your Hi-Doctor physician will discuss potential side effects specific to the prescribed medication and provide guidance on when to seek medical attention or discontinue treatment. Always follow your doctor's instructions. If you experience severe or persistent side effects, contact a healthcare professional immediately.
Why Hi-Doctor vs. walking into a clinic
Choosing Hi-Doctor offers distinct advantages over traditional clinic visits, especially for obtaining a prescription for approved weight-loss medication:
- Convenience: Complete your consultation from anywhere, anytime, without travel or waiting rooms.
- Speed: Get a doctor's review and prescription in under 24 hours, often much faster than scheduling an in-person appointment.
- Cost-Effective: A flat 25 € consultation fee with a money-back guarantee means no hidden costs or wasted trips.
- EU-Wide Recognition: Our REMPE prescriptions are designed for EU-wide recognition, meaning you can pick up your medication at any EU pharmacy.
- Privacy & Security: Your case review is confidential, RGPD-compliant, and fully auditable through your secure online account.
- Trusted Care: With 50,000+ patients served and a 4.8 Trustpilot rating, Hi-Doctor connects you with EU-licensed doctors who adhere to the highest medical standards.
"Over 50,000 patients served with an average Trustpilot rating of 4.8 stars highlight Hi-Doctor's commitment to accessible, quality online healthcare across the EU."
COMMON QUESTIONS
Frequently asked questions
No, Bimatoprost is not currently approved for medical use in the EU, including Amsterdam. Purchasing it online from unregulated sources is illegal and carries significant health risks due to the potential for counterfeit products and lack of medical supervision.
